KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $44.2 million.

  • Idexx Laboratories' Net Cash Flow rose 14493.73% to $44.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$101.9 million, marking a year-over-year decrease of 26451.61%. This contributed to the annual value of -$156.1 million for FY2024, which is 14602.19% down from last year.
  • Per Idexx Laboratories' latest filing, its Net Cash Flow stood at $44.2 million for Q3 2025, which was up 14493.73% from -$13.5 million recorded in Q2 2025.
  • Idexx Laboratories' Net Cash Flow's 5-year high stood at $201.6 million during Q3 2023, with a 5-year trough of -$122.0 million in Q1 2025.
  • Over the past 5 years, Idexx Laboratories' median Net Cash Flow value was -$9.0 million (recorded in 2022), while the average stood at -$8.8 million.
  • In the last 5 years, Idexx Laboratories' Net Cash Flow soared by 709134.62% in 2022 and then tumbled by 302101.19% in 2024.
  • Over the past 5 years, Idexx Laboratories' Net Cash Flow (Quarter) stood at $104000.0 in 2021, then skyrocketed by 7091.35% to $7.5 million in 2022, then surged by 1472.03% to $117.6 million in 2023, then crashed by 109.02% to -$10.6 million in 2024, then skyrocketed by 516.59% to $44.2 million in 2025.
  • Its Net Cash Flow stands at $44.2 million for Q3 2025, versus -$13.5 million for Q2 2025 and -$122.0 million for Q1 2025.